T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Dave & Buster's
PLAY
$358M
| $1.27M | ﹤0.01% |
26,481
+2,499
| +10% | +$97.6K |
|
1927
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.27M | ﹤0.01% |
24,315
| – | – |
|
1928
Ennis
EBF
$559M
| $1.26M | ﹤0.01% |
59,082
+2,480
| +4% | +$49.1K |
|
|
ESGR
1929
DELISTED
Enstar Group
ESGR
| $1.26M | ﹤0.01% |
5,109
-703
| -12% | -$160K |
|
|
ONEM
1930
DELISTED
1Life Healthcare
ONEM
| $1.26M | ﹤0.01% |
32,272
+497
| +2% | +$23.3K |
|
1931
Franklin Electric
FELE
$4.68B
| $1.25M | ﹤0.01% |
15,882
-1,197
| -7% | -$89.7K |
|
1932
Opko Health
OPK
$993M
| $1.25M | ﹤0.01% |
292,197
+47,027
| +19% | +$225K |
|
1933
FNB Corp
FNB
$6.93B
| $1.25M | ﹤0.01% |
98,645
+9,628
| +11% | +$111K |
|
1934
Silgan Holdings
SLGN
$4.44B
| $1.25M | ﹤0.01% |
29,822
+61
| +0.2% | +$2.38K |
|
|
MZTI
1935
The Marzetti Company
MZTI
$3.18B
| $1.25M | ﹤0.01% |
7,140
-304
| -4% | -$54.5K |
|
1936
Suncor Energy
SU
$77.8B
| $1.25M | ﹤0.01% |
59,699
-12
| -0% | -$235 |
|
1937
TriNet
TNET
$3.15B
| $1.25M | ﹤0.01% |
15,992
-2,891
| -15% | -$233K |
|
1938
Qiagen
QGEN
$8.91B
| $1.25M | ﹤0.01% |
24,132
-2,802
| -10% | -$154K |
|
1939
PUT
Invesco QQQ Trust
QQQ
$485B
| $1.25M | ﹤0.01% |
+3,900
| New | +$1.25M |
|
1940
Cohu
COHU
$2.73B
| $1.24M | ﹤0.01% |
29,628
-10,230
| -26% | -$451K |
|
1941
Kirby Corp
KEX
$7.29B
| $1.24M | ﹤0.01% |
20,516
-834
| -4% | -$50.1K |
|
1942
Mercury Insurance
MCY
$5.82B
| $1.24M | ﹤0.01% |
20,347
-3,689
| -15% | -$211K |
|
1943
Primoris Services
PRIM
$4.43B
| $1.24M | ﹤0.01% |
37,303
+4,348
| +13% | +$143K |
|
1944
Riot Platforms
RIOT
$6.94B
| $1.24M | ﹤0.01% |
+23,200
| New | +$939K |
|
1945
Fidelity MSCI Health Care Index ETF
FHLC
$3.4B
| $1.24M | ﹤0.01% |
20,944
| – | – |
|
1946
John Wiley & Sons Class A
WLY
$2.61B
| $1.23M | ﹤0.01% |
22,710
-784
| -3% | -$39.9K |
|
|
LTHM
1947
DELISTED
Livent Corporation
LTHM
| $1.23M | ﹤0.01% |
71,075
+25,875
| +57% | +$508K |
|
1948
Integer Holdings
ITGR
$4.26B
| $1.23M | ﹤0.01% |
13,357
-400
| -3% | -$33.8K |
|
1949
Apogee Enterprises
APOG
$883M
| $1.23M | ﹤0.01% |
30,061
-4,825
| -14% | -$182K |
|
|
CVSA
1950
Covista Inc
CVSA
$4.47B
| $1.23M | ﹤0.01% |
31,092
-4,124
| -12% | -$161K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.